I. Horvath (Budakeszi, Hungary), P. Gibson (Newcastle, Australia)
Inflammatory cell profiles in asthmatic infants assessed by induced sputum
N. Champs, L. Couderc, M. Lubrano, I. Michelet, C. Marguet (Rouen, France; Belo Horizonte, Brazil)
|   |
Asthma and persistent low sputum eosinophilia
M. Latorre, E. Bacci, L. Melosini, F. Novelli, S. Cianchetti, L. Ruocco, M. L. Bartoli, F. L. Dente, A. Di Franco, P. L. Paggiaro (Pisa, Italy)
| |
Determinants and reference values for fraction of exhaled nitric oxide (FENO) in healthy, non-smoking Chinese adults
A. Tung, F. Ko, D. Hui (Shatin, Hong Kong)
| |
Differences between exhaled nitric oxide levels in atopic children allergic and non allergic to cat dander
T. Grzelewski, I. Stelmach (Lodz, Poland)
| |
Association of elevated exhaled nitric oxide and eosinophilic airway disease in elite athletes with EIB
N. Martin, M. Lindley, W. Monteiro, B. Hargadon, I. Pavord (Leicester, Loughborough, United Kingdom)
| |
Correlation between exhaled nitric oxide, airway hyper responsiveness and pulmonary function data in patients with suspected asthma
G. Strazda, N. Jurka, M. Bukovskis, Z. Balode, I. Taivans (Riga, Latvia)
| |
High levels of fractional exhaled nitric oxide (FeNO) in severe oral steroid-dependent asthma are associated with eosinophilia and atopy
S. Hashimoto, A. Ten Brinke, A. C. Roldaan, H. P. van Veen, G. M. Möller, J. K. Sont, E. J. M. Weersink, J. S. van der Zee, P. J. Sterk, E. H. Bel (Amsterdam, Leeuwarden, den Haag, Enschede, Leiden, Netherlands)
| |
Exhaled nitric oxide and exhaled breath condensate pH in smoking asthma
G. Hillas, S. Loukides, V. Delimpoura, V. Bessa, E. Tseliou, K. Matzouranis, G. Papadaki, K. Kontogianni, C. Roussos, S. Papiris, P. Bakakos (Athens, Greece)
| |
Levels of asthma control and exhaled nitric oxide
E. Heffler, S. Pizzimenti, G. Guida, I. Badiu, L. Bommarito, F. Nebiolo, G. Rolla (Torino, Italy)
| |
Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control
J. Saito, Y. Sato, T. Nikaido, Y. Inokoshi, K. Saito, N. Nakagawa, A. Fukuhara, T. Ishii, S. Sato, X. Wang, Y. Tanino, T. Ishida, M. Munakata (Fukushima, Japan)
| |
Reversibility test may be another marker of asthma control
L. Melosini, F. L. Dente, M. Latorre, F. Novelli, E. Bacci, A. Di Franco, M. Carli, P. Paggiaro (Pisa, Italy)
| |
Exercise induced contraction of conducting airways in asthmatic children is significantly related to an increased exhaled nitric oxide
C. Schweitzer, A. Sellier-Tatopoulos, E. Bernard, C. Bonabel-Choné, F. Marchal (Vandoeuvre lès Nancy, France)
| |
AHR to mannitol is associated with ongoing airway inflammation – a random sample population study
C. Porsbjerg, A. Sverrild, V. Backer (Copenhagen, Denmark)
| |
Aiway inflammation after mannitol challenge in elite athletes
M. J. Rodriguez Nieto, M. Fernandez Nieto, F. Villar Alvarez, E. Aguado, M. Garcia del Potro, V. Del Pozo, J. Sastre, N. Gonzalez Mangado (Madrid, Spain)
| |
Exhaled adenosine triphosphate (ATP) concentration is elevated in stable asthmatic patients compared to control subjects
Z. Lazar, L. Cervenak, M. Orosz, G. Galffy, N. Gyulai, G. Losonczy, I. Horvath (Budapest, Hungary)
| |
Development of an exhaled breath protein pattern to distinguish asthmatic from healthy children
K. Bloemen, R. Van Den Heuvel, E. Govarts, G. Koppen, V. Nelen, E. Witters, K. Desager, G. Schoeters (Mol, Antwerp, Belgium)
| |
Comparison of Nε-(carboxymethyl)lysine levels and percentage of eosinophils in induced sputum for assessment of small airway involvements in asthma
S. Kyoh, H. Kanazawa, T. Kodama, Y. Tochino, K. Asai, K. Hirata (Osaka, Japan)
| |
Differential ion mobility spectrometry for detection of metabolites in exhaled breath in airway diseases
A. Kikowatz, G. Becher, W. Steinhaeusser, S. Dietze, E. Beck (Berlin, Bernau, Hoechberg, Ruedersdorf, Germany)
| |
The 3-nitrothyrozine and total nitrate/nitrite (TNN) levels in exhaled breath condensate (EBC) in patients with bronchial asthma (BA)
I. A. Klimanov, S. K. Soodaeva, A. V. Lisitsa, S. B. Bolevich (Moscow, Russian Federation)
| |
Endothelin -1 in exhaled breath condensate during omalizumab therapy in patients with severe persistent allergic asthma
R. Skiepko, Z. Zietkowski, M. Tomasiak-Lozowska, D. Lenczewska, A. Bodzenta-Lukaszyk (Bialystok, Poland)
| |